Showing results (141-150 of 224) with videos related to

Sort By:
Pageof 23
Kidney Medicine|March 5, 2026
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging TherapiesMahtab Mashayekhi, Jonathan E Zuckerman, Jonathan Barratt, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|September 11, 2019
Peritoneal Ultrafiltration for Heart Failure: Lessons from a Randomized Controlled TrialHari Dukka, Philip A Kalra, Martin Wilkie, et al.
Kidney International Reports|December 19, 2024
Scoping Review of Economic Analyses of Rare Kidney DiseasesBlake Angell, Siyuan Wang, Thomas Gadsden, et al.
The New England Journal of Medicine|October 26, 2024
Atrasentan in Patients with IgA NephropathyHiddo J L Heerspink, Meg Jardine, Donald E Kohan, et al.
Kidney International|June 28, 2025
Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and safety of felzartamab for IgA nephropathyJürgen Floege, Richard Lafayette, Jonathan Barratt, et al.
The New England Journal of Medicine|November 2, 2023
A Phase 2 Trial of Sibeprenlimab in Patients with IgA NephropathyMohit Mathur, Jonathan Barratt, Bobby Chacko, et al.
Kidney International|March 29, 2026
Absence of glomerular IgA1 deposition despite overexpression of galactose-deficient IgA1 in the B cell c1galt1 knockout mouseJingyi Wu, Tong Xie, Zhao Zhang, et al.
Kidney International Reports|October 26, 2020
IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK BiobankKittiya Sukcharoen, Seth A Sharp, Nicholas J Thomas, et al.
Kidney International|June 7, 2025
Zigakibart demonstrates clinical safety and efficacy in a Phase 1/2 trial of healthy volunteers and patients with IgA nephropathyLaura Kooienga, Jeannette Lo, Eun Young Lee, et al.
Kidney International Reports|July 18, 2025
Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1283-1287]Sean J Barbour, Rosanna Coppo, Jonathan Barratt, et al.
Pageof 23